Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

News

Kelly succeeds Murphy as CMO

Posted 22 December 2020 AM

Professor Paul Kelly, a familiar face on our television screens for months, and former deputy to now Health Department Secretary Dr Brendan Murphy, has been appointed as the nation's Chief Medical Officer (CMO).

The government has welcomed the appointment, noting that Professor Kelly had been acting in the role since June 2020 when Dr Murphy moved to Health.

Professor Kelly has been intimately involved in Australia-s response to COVID-19 from the earliest days of the pandemic as well as in the health response to the devastating 2019-20 bushfires.

"Since Dr Brendan Murphy's appointment as Secretary of the Department of Health, Professor Kelly has ably led the response to COVID-19, including as Chair of the Australian Health Protection Principal Committee (AHPPC)," Prime Minister Scott Morrison's office said.

"His appointment to the permanent role of CMO ensures Australia remains in very capable hands. He was successful after a rigorous and highly competitive selection process conducted by the Department of Health.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Biden and the MA agreement
'Global decisions' will influence ongoing negotiations
Special Report
PBAC March agenda
Every major and minor sub sorted by indication
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas